Le Lézard
Classified in: Health
Subjects: AWD, MAT

Coda Signature Co-Founder and CEO, Mark Grindeland Named Cannabis Industry MVP


DENVER, Dec. 13, 2018 /PRNewswire/ -- Coda Signature, a leading manufacturer of premium, cannabis-infused edibles, topicals and concentrates for medicinal and adult-use, is pleased to announce that the company's co-founder and CEO, Mark Grindeland was recognized at the recent Cannabis Business Awards as one of ten MVPs in the cannabis industry for 2018.

The Cannabis Business Awards are held every year by Clover Leaf University to recognize cannabis companies and business influencers who are helping to shape the industry on a national level. The MVPs hailed from a range of companies and parts of the country. Joining Mark Grindeland on the list were:

Vicente Sederberg - Law Firm
Nancy Whiteman - Wana Brands
Max Cohen - The Clinic
TJ Joudeh ? Starbuds
Danny Danko - High Times
Steve Bloom - Freedom Leaf
Scherill Murray Powell - Canna Urban
Sarah Stenuf - Veteran's Ananda
Emmanual Bernal - Wolf Pac Cannabis

"All of us at Coda Signature are so proud of Mark," commented Elizabeth Cooke, co-founder and president, Coda Signature. "We have worked hard to set the standard of excellence in a new and evolving marketplace. As CEO, Mark has brought the fundamentals of good business practices to the creativity of the cannabis movement and in doing so has helped elevate and build credibility for the industry."

Coda Signature crafts premium cannabis-infused edibles, topicals and concentrates for medicinal and adult-use. Recognized as a market innovator, Coda Signature products feature bold flavor combinations and rejuvenating formulas made from the highest-quality, natural ingredients. Founded in 2015, the company's award-winning products are available in almost 600 dispensaries across Colorado today and will be coming to California in early 2019. To learn more, visit www.codasignature.com.

Media contact:
Drew White
[email protected]
631-520-1435

SOURCE Coda Signature


These press releases may also interest you

at 20:40
Rakovina Therapeutics Inc. a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies announced the financial results for its fourth quarter and fiscal year ending December 31, 2023 and...

at 19:40
ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines, today announced its ongoing commitment to exploring the therapeutic opportunity of glycobiology through support for ongoing research at GanNA Bio, and the...

at 19:05
Appili Therapeutics Inc. (the "Company" or "Appili"), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, today announced it has secured additional bridge financing in the amount of C$300,000...

at 19:00
David J. Dykeman, co-chair of the Life Sciences & Medical...

at 18:30
Aspire Health Alliance ("Aspire Health") is a company headquartered in Braintree, Massachusetts, that provides behavioral health services in the community.  Aspire Health experienced a data security incident that may have involved personal and...

at 17:21
Chemistree Technology Inc. (US OTC: CHMJF) (the "Company" or "Chemistree"), is pleased to announce that the adjourned extraordinary meeting of the holders of the 10% senior unsecured convertible debentures of the Company (the "Debentures") was...



News published on and distributed by: